One of the most significant recent realizations in biology and medicine is the key role that noncoding RNAs (ncRNAs) play in numerous and important biological processes including many aspects of gene expression. Not surprisingly, the impact of ncRNA function on human health and disease is proving to be broad and substantial. Most non-coding RNAs assemble with partner proteins to form non-coding RNA-protein complexes (ncRNPs), and these function in diverse cellular processes. The major objective of this proposal is to obtain a detailed understanding of the biogenesis and function of two distinct and important classes of ncRNPs through biochemical and molecular analysis.
Our first aim i s to determine how the four essential proteins and guide RNA of the H/ACA RNP assemble and function together to carry out RNA modification. In humans, H/ACA RNPs are required for the production of the pre-mRNA splicing and protein translation machinery as well as for genome stability. Our work on this complex has provided new insight into the etiology of dyskerotosis congenita. The experiments proposed in our second aim will provide substantial information on the biogenesis and function of a newly recognized prokaryotic genome defense system. This pathway is strongly implicated in defense against viruses and other mobile genetic elements in prokaryotes including important human pathogens. This system represents a major new RNA silencing pathway with the potential to provide insight on other silencing pathways. Importantly, this pathway may provide a means for both experimental gene silencing and development of novel classes of therapeutics effective in the broad range of prokaryotes in which the system is found. Together, the proposed studies have great potential for significant contributions to human health and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM054682-11S1
Application #
7892747
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Bender, Michael T
Project Start
2009-08-13
Project End
2011-07-31
Budget Start
2009-08-13
Budget End
2011-07-31
Support Year
11
Fiscal Year
2009
Total Cost
$284,128
Indirect Cost
Name
University of Georgia
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Elmore, Joshua R; Sheppard, Nolan F; Ramia, Nancy et al. (2016) Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system. Genes Dev 30:447-59
Sheppard, Nolan F; Glover 3rd, Claiborne V C; Terns, Rebecca M et al. (2016) The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease. RNA 22:216-24
Makarova, Kira S; Wolf, Yuri I; Alkhnbashi, Omer S et al. (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722-36
Swarts, Daan C; Hegge, Jorrit W; Hinojo, Ismael et al. (2015) Argonaute of the archaeon Pyrococcus furiosus is a DNA-guided nuclease that targets cognate DNA. Nucleic Acids Res 43:5120-9
Elmore, Joshua; Deighan, Trace; Westpheling, Jan et al. (2015) DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus. Nucleic Acids Res 43:10353-63
Majumdar, Sonali; Zhao, Peng; Pfister, Neil T et al. (2015) Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus. RNA 21:1147-58
Hale, Caryn R; Cocozaki, Alexis; Li, Hong et al. (2014) Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev 28:2432-43
Terns, Rebecca M; Terns, Michael P (2014) CRISPR-based technologies: prokaryotic defense weapons repurposed. Trends Genet 30:111-8
Ramia, Nancy F; Spilman, Michael; Tang, Li et al. (2014) Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep 9:1610-1617
Shao, Yaming; Cocozaki, Alexis I; Ramia, Nancy F et al. (2013) Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex. Structure 21:376-84

Showing the most recent 10 out of 41 publications